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Abstract: Plasticity of synaptic strength and density is a vital mechanism enabling memory consolidation,
learning, and neurodevelopment. It is strongly dependent on the intact function of N-Methyl-d-Aspartate
Receptors (NMDAR). The importance of NMDAR is further evident as their dysfunction is involved in
many diseases such as schizophrenia, Alzheimer’s disease, neurodevelopmental disorders, and epilepsies.
Synaptic plasticity is thought to be reflected by changes of sleep slow wave slopes across the night,
namely higher slopes after wakefulness at the beginning of sleep than after a night of sleep. Hence, a
functional NMDAR deficiency should theoretically lead to altered overnight changes of slow wave slopes.
Here we investigated whether pediatric patients with anti-NMDAR encephalitis, being a very rare but
unique human model of NMDAR deficiency due to autoantibodies against receptor subunits, indeed show
alterations in this sleep EEG marker for synaptic plasticity. We retrospectively analyzed 12 whole-night
EEGs of 9 patients (age 4.3-20.8 years, 7 females) and compared them to a control group of 45 healthy
individuals with the same age distribution. Slow wave slopes were calculated for the first and last hour of
Non-Rapid Eye Movement (NREM) sleep (factor ’hour’) for patients and controls (factor ’group’). There
was a significant interaction between ’hour’ and ’group’ (p = 0.013), with patients showing a smaller
overnight decrease of slow wave slopes than controls. Moreover, we found smaller slopes during the first
hour in patients (p = 0.022), whereas there was no group difference during the last hour of NREM sleep
(p = 0.980). Importantly, the distribution of sleep stages was not different between the groups, and in
our main analyses of patients without severe disturbance of sleep architecture, neither was the incidence
of slow waves. These possible confounders could therefore not account for the differences in the slow
wave slope values, which we also saw in the analysis of the whole sample of EEGs. These results suggest
that quantitative EEG analysis of slow wave characteristics may reveal impaired synaptic plasticity in
patients with anti-NMDAR encephalitis, a human model of functional NMDAR deficiency. Thus, in the
future, the changes of sleep slow wave slopes may contribute to the development of electrophysiological
biomarkers of functional NMDAR deficiency and synaptic plasticity in general.
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a b s t r a c t 
Plasticity of synaptic strength and density is a vital mechanism enabling memory consolidation, learning, and neu- 
rodevelopment. It is strongly dependent on the intact function of N-Methyl- d -Aspartate Receptors (NMDAR). The 
importance of NMDAR is further evident as their dysfunction is involved in many diseases such as schizophrenia, 
Alzheimer’s disease, neurodevelopmental disorders, and epilepsies. Synaptic plasticity is thought to be reflected 
by changes of sleep slow wave slopes across the night, namely higher slopes after wakefulness at the beginning 
of sleep than after a night of sleep. Hence, a functional NMDAR deficiency should theoretically lead to altered 
overnight changes of slow wave slopes. Here we investigated whether pediatric patients with anti-NMDAR en- 
cephalitis, being a very rare but unique human model of NMDAR deficiency due to autoantibodies against receptor 
subunits, indeed show alterations in this sleep EEG marker for synaptic plasticity. 
We retrospectively analyzed 12 whole-night EEGs of 9 patients (age 4.3–20.8 years, 7 females) and compared 
them to a control group of 45 healthy individuals with the same age distribution. Slow wave slopes were calculated 
for the first and last hour of Non-Rapid Eye Movement (NREM) sleep (factor ‘hour’) for patients and controls 
(factor ‘group’). There was a significant interaction between ‘hour’ and ‘group’ ( p = 0.013), with patients showing 
a smaller overnight decrease of slow wave slopes than controls. Moreover, we found smaller slopes during the 
first hour in patients ( p = 0.022), whereas there was no group difference during the last hour of NREM sleep 
( p = 0.980). Importantly, the distribution of sleep stages was not different between the groups, and in our main 
analyses of patients without severe disturbance of sleep architecture, neither was the incidence of slow waves. 
These possible confounders could therefore not account for the differences in the slow wave slope values, which 
we also saw in the analysis of the whole sample of EEGs. These results suggest that quantitative EEG analysis of 
slow wave characteristics may reveal impaired synaptic plasticity in patients with anti-NMDAR encephalitis, a 
human model of functional NMDAR deficiency. Thus, in the future, the changes of sleep slow wave slopes may 
contribute to the development of electrophysiological biomarkers of functional NMDAR deficiency and synaptic 
plasticity in general. 
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1. Introduction 
N-methyl- d -aspartate receptors (NMDAR) are a class of ionotropic 
glutamate receptors ubiquitously distributed throughout the central ner- 
vous system. Due to their importance, it is not surprising that a dys- 
function of NMDAR is involved in many diseases such as schizophre- 
nia ( Tsai and Coyle, 2002 ), Alzheimer’s disease ( Zhang et al., 2016 ), 
and epilepsies and neurodevelopmental disorders ( Burnashev and 
Szepetowski, 2015 ). NMDAR are primarily known for their pivotal role 
in long-term synaptic plasticity ( Dupuis et al., 2014 ; Escobar et al., 
1998 ). Synaptic plasticity involves behavior-dependent synaptic po- 
tentiation during wakefulness, being the basic mechanism of learn- 
ing, and behavior-independent renormalization of synaptic strength and 
density during sleep, which has been hypothesized to ensure synap- 
tic homeostasis ( Tononi and Cirelli, 2014 ). Various studies suggested 
that the processes that underlie synaptic plasticity and homeostasis, 
i.e. changes in net synaptic strength and synaptic density, are re- 
flected by changes of sleep slow wave (0.5 – 4 Hz) characteristics 
measured in the surface EEG ( Esser et al., 2007 ; Riedner et al., 2007 ; 
Vyazovskiy et al., 2009 ). 
Slow waves stem from (near) synchronous activity of large pop- 
ulations of cortical neurons ( Esser et al., 2007 ; Vyazovskiy et al., 
2009 ), which has been related to the strength of synaptic connections 
( Esser et al., 2007 ). They are most prominent in Non-Rapid Eye Move- 
ment (NREM) sleep and can be characterized by various parameters 
such as incidence, power, amplitude, and slope ( Esser et al., 2007 ). 
Of these, the slope has been suggested to be the preferred EEG marker 
for cortical synchrony, being the closest reflection of synaptic strength 
( Riedner et al., 2007 ; Vyazovskiy et al., 2009 ). Accordingly, changes 
of slow wave slopes from the First Hour (FH) to the Last Hour (LH) of 
NREM sleep have been used to indirectly measure synaptic plasticity 
( Bölsterli et al., 2011 ; Fattinger et al., 2015 ). This typically results in 
steeper slopes of slow waves at the beginning of sleep because of synap- 
tic potentiation during previous wakefulness and a homeostatic decrease 
of slow wave slopes across the night ( Riedner et al., 2007 ). 
The analysis of sleep slow waves has indicated that synaptic plas- 
ticity may be challenged in various conditions, including major de- 
pressive disorder ( Armitage et al., 2000 ), encephalopathy with sta- 
tus epilepticus during sleep (ESES) ( Bölsterli et al., 2011 ) and in- 
fantile spasms ( Fattinger et al., 2015 ). Since synaptic plasticity re- 
quires properly functioning NMDAR, a dysfunction would expectably 
result in altered changes of slow wave characteristics during a night’s 
sleep. Such a functional NMDAR deficiency may emerge in differ- 
ent ways, for example by interventions such as gene editing and re- 
ceptor antagonism ( Campbell and Feinberg, 1996 ; Miyamoto et al., 
2003 ), or by antibodies against the NMDAR as seen in anti-NMDAR 
encephalitis. 
Anti-NMDAR encephalitis is a well-recognized but very rare dis- 
ease due to autoantibodies against the NR1-subunit of NMDAR 
( Dalmau et al., 2008 , 2007 ). Anti-NMDAR antibodies disturb receptor 
functionality by cross-linking them, which leads to their internalization 
into neurons, causing a functional NMDAR deficiency ( Hughes et al., 
2010 ). Accordingly, such patients constitute a human model of NMDAR 
deficiency, which suggests that the receptors’ role in synaptic plasticity 
is impaired. 
In this retrospective, multicenter, case-control study, we hypothe- 
sized that the changes of slow wave slopes across the night in pediatric 
patients with anti-NMDAR encephalitis, representing a human model of 
NMDAR deficiency, are altered, i.e. show diminished patterns of change. 
To this end, we compared changes of slow wave slopes from the FH to 
the LH of NREM sleep between patients and healthy controls of corre- 
sponding age. To rule out that differences in other sleep variables such 
as sleep stage distributions or the mere counts of slow waves would drive 
group differences in slow wave slopes, we additionally compared these 
variables between the groups. 
2. Materials and Methods 
2.1. Participants 
Patients diagnosed with anti-NMDAR encephalitis were provided 
by the Department of Neuropediatrics, University Children’s Hospi- 
tal Zurich (Switzerland); the Department for Women’s and Children’s 
Health, Pediatric Neurology and Neurophysiology Unit, University of 
Padua (Italy); the Department of Pediatric Neurology, Children’s Hospi- 
tal Datteln, University Witten/Herdecke (Germany); the University Hos- 
pital Muenster, Westfalian Wilhelms University (Germany); and the Ser- 
vice de Pédiatrie, CHU d’Angers (France). Twenty-one EEGs from thir- 
teen patients (ten females) recorded between 2008 and 2019 were avail- 
able. We included patients that met all the following inclusion criteria: 
• Detection of anti-NMDAR antibodies in serum and/or cerebrospinal 
fluid 
• At least one whole-night sleep-EEG recording of sufficing data qual- 
ity and without highly pathological changes that allowed scoring of 
sleep stages 
• Under the age of 21 years at the time of EEG recording 
Nine EEGs from nine patients had to be excluded because of the fol- 
lowing reasons: inability to score sleep stages, for example due to exces- 
sive artifacts (six EEGs); the EEG not being a whole-night registration 
(one EEG); incompleteness of the EEG (one EEG); and a lack of sleep dur- 
ing the recording (one EEG). Consequently, we included 12 whole-night 
EEGs from 9 patients (7 females, age 4.3–20.8 years, mean 12.3 years) 
at different stages of their disease. Clinical and electrographic charac- 
teristics of included patients are provided in Table 1 and Supplementary 
Table 1. 
As representative references for each patient, we included five 
healthy controls with one whole-night EEG recording from studies con- 
ducted between 2008 and 2019 by the research group of Reto Hu- 
ber from the University Children’s Hospital Zurich ( Kurth et al., 2012 ; 
Wehrle et al., 2017 ; Volk et al., 2019 ; unpublished observations). Age- 
wise, these controls differed at most 1.1 years from the corresponding 
patient, resulting in an age distribution in controls (age 4.2–21.4 years, 
mean 12.4 years) that was comparable to that in patients. This proce- 
dure was carried out to avoid that age-related differences in sleep slow 
wave characteristics could eventually drive differences between patients 
and controls ( Kurth et al., 2010b ). Moreover, the sex of controls was 
matched for all but one patient. For this young male patient (7.4 years), 
we included three male and two female controls, as no more data of 
male controls in that age range were available. Importantly, sex influ- 
ences on sleep parameters are thought to be minimal before puberty 
( Johnson et al., 2006 ; Knutson, 2005 ). 
This study was performed at the University Children’s Hospital 
Zurich. All participants or their legal representatives gave written in- 
formed consent for the use of their non-identifiable, health-related data 
for research purposes – acknowledged by their local authorities. Ethical 
approval was provided by the ethical committee of the canton of Zurich 
(BASEC Nr. 2016–02154). 
2.2. EEG recordings 
The recordings from the patients in Zurich were performed using 
a Neurofile XP EEG System (Natus Europe GmbH, Munich, Germany), 
with 19 electrodes according to the international 10–20 system. Their 
EEG data were analogously band-pass filtered (0.016–300 Hz), saved at 
256 Hz and then digitally band-pass filtered (0.53–70 Hz). At the Chil- 
dren’s Hospital Datteln, a Neurofax EEG-9210 System (Berger Medizin- 
technik GmbH, Gleisdorf, Österreich) was used. The signals were stored 
at 200 Hz and digitally band-pass filtered (0.53–70 Hz). At the Pedi- 
atric Clinical Hospital of Padua, EEG data were acquired with Galileo NT 
Software (EB Neuro S.p.A, Florence, Italy), analogously wide-band fil- 
tered (0–20 kHz) and consequently saved at 256 Hz. The EEGs from the 
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Table 1 
Clinical and electrographic characteristics of anti-NMDAR encephalitis patients at the time of EEG registration. 
Patient 
(#) Sex EEG 
Age 
(years) Time since diagnosis Clinical presentation Sleep EEG structure anomalies 
1 f A ̂ 14.7 ≅3 mt Started to speak 2d before EEG, 
speech problems (single words 
expressed, slurred pronunciation). 
Child-like behavior. Fluctuating 
confusion, disorientation, agitation. 
Restlessness. Improving flaccid paresis 
of the legs (critical illness myopathy, 
75d in the intensive care unit) 
Severe sleep fragmentation 
B 14.9 ≅5 1 
2 mt Clear clinical improvement compared 
to EEG A. Increased alertness, speaks 
more, still slightly blurred and 
word-finding problems, better motor 
skills (sitting, walking some steps 
possible). Behavioral inflexibility 
None 
2 m A 7.4 < 1 mt The morning before EEG, focal seizure 
with clonic jerking of the right-side of 
mouth. Mood swings and slurred 
speech 
None 
B 7.4 < 1 mt Clinical improvement compared to 
EEG A. Slight truncal ataxia (abnormal 
line gait with closed eyes). Emotional 
lability. Good visuoconstructive 
performance. Language impairment 
(pronunciation, word-finding, speech 
planning, vowel differentiation, and 
auditory memory; but normal 
comprehension), reduced memory 
capacity and concentration 
Period (2.81 hrs) of 
continuous wakefulness after 
the start of NREM sleep 
3 f A ̂ 4.3 ≅1 1 
2 mt Mutism. Interaction by eye contact 
preserved. Receptive language better 
preserved but limited to simple 
orders. Chorea, allowing walking with 
assistance and impairing fine motor 
skills. Neuropsychological testing 
impossible 
Disrupted sleep architecture; 
frontal seizure patterns 
4 f A 17.9 ≅5 mt No abnormalities None 
5 ∗ f A 20.8 ≅63 mt after diagnosis, 
48 mt after relapse 
No abnormalities Period (3.24 hrs) of 
continuous wakefulness after 
the start of NREM sleep 
6 m A 13.0 ≅1 1 
2 mt mRS 3. Can walk approximately ten 
steps without support. Starting oral 
feeding 
None 
B 13.0 ≅2 mt mRS 3. Better sleep compared to EEG 
A. Echolalia. Hyperphagia. Intermittent 
verbal aggressiveness 
None 
7 f A 9.5 ≅1 mt mRS 2. Speech difficulties 
(pronunciation and word finding). 
Fatigue 
None 
8 f A ̂ 9.7 ≅1 mt Clinically, long sleep episodes. Eats 
and drinks in drowsiness, orofacial 
dyskinesia. Muscular hypotonia in 
extremities. Stable trunk. Weak 
muscle tendon reflexes 
Severe sleep fragmentation 
9 f A 13.3 Diagnosis made ≅3 mt 
after EEG (the result of 
CSF specimen, taken at 
the time of EEG, 
received after 3 mt) 
Fluctuating clinical picture with 
hallucinations, disorientation (no 
recognition of parents, orientation to 
person, not time and place), child-like 
behaviour, amnesia, urine 
incontinence, fluctuating vigilance 
with intermittent severe agitation, 
expression of single words, 
pronounciation difficulties, swallowing 
problems, uncoordinated movements 
of all limbs and mouth. 
None 
An EEG designated ‘A’ or ‘B’ indicates whether it concerns the first or, if applicable, the second available recording for the same patient, 
respectively. 
ˆ EEGs not in the main statistical analysis (see 2. Materials and Methods for details). 
∗ Patient not included in the statistical analysis, but slow wave analysis results assessed individually (see 2. Materials and Methods for 
details). 
d = day(s), hrs = hours, mRS = modified Rankin Scale, mt = month(s), NREM = Non-Rapid Eye Movement. 
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Fig. 1. Example of a slow wave slope calculation demonstrated with an excerpt of the EEG of patient #5. The gray and black lines illustrate the EEG signal before 
and after application of the 0.5–4 Hz digital band-pass filter, respectively. Examples of detected zero-crossings of the band-pass filtered signal are depicted by blue 
circles, whereas the most negative value of the deflection in between is highlighted by a green circle. The slope of the corresponding slow wave was calculated based 
on the red straight line that passes through the minimum and the next zero-crossing. 
Fig. 2. Slow wave slope for the first and last hour of Non-Rapid Eye 
Movement (NREM) sleep. Group mean values are provided for pa- 
tients (black diamonds and dashed line) and control participants (grey 
circles and solid line). Error bars represent the standard error of the 
mean. The asterisk ( ∗ ) indicates a significant interaction effect for 
‘hour’ and ‘group’, i.e. the overnight (first hour to last hour of NREM 
sleep) change of the slow wave slope is different in patients and con- 
trols. Post hoc analyzes revealed a significant group difference for the 
first hour (marked by a black, solid triangle; p < 0.05; two-tailed in- 
dependent samples t -test; Bonferroni corrected by multiplying the p - 
value by the number of post hoc tests), but not for the last hour of 
NREM sleep. . 
University Hospital Angers were registered with a Deltamed Brainbox- 
1042 EEG amplifier (Natus Europe GmbH, Munich, Germany), stored at 
256 Hz, and digitally high- and low-pass filtered at 0.17 Hz and 100 Hz, 
respectively. The EEGs from patients in Angers, Datteln and Padua had 
at least eight EEG electrodes placed on 10–20-positions. The six com- 
mon electrodes among all EEGs were O1, O2, Fp1, Fp2 and temporal 
electrodes (either T3 and T4, or T5 and T6). The EEGs from Münster 
were excluded due to excessive artifacts. 
To avoid inter-rater variability, all sleep stage scoring for patients 
was done by a single, trained EEG technician (H.C.) according to the 
standard criteria from the American Association of Sleep Medicine 
(AASM) ( Iber et al., 2007 ), applied to 20 ‑sec epochs. 
EEGs for controls were recorded using a 128-channels high-density 
EEG system (Electrical Geodesics, Inc.; Sensor Net for long-term moni- 
toring). The data were sampled at 500 Hz (analogously filtered between 
0.01 and 200 Hz) and then digitally band-pass filtered (0.5–50 Hz). Scor- 
ing was done by investigators of the original studies ( Kurth et al., 2012 ; 
Wehrle et al., 2017 ; Volk et al., 2019 ; unpublished observations) ac- 
cording to the guidelines from the AASM ( Iber et al., 2007 ), applied to 
20 ‑sec epochs. 
2.3. EEG analyzes 
After acquisition and scoring of all patient and control EEG record- 
ings, data were further analyzed in MATLAB R2017b (The Math- 
Works, Inc., Natick, MA). All EEGs were downsampled to 128 Hz, af- 
ter which semi-automatic artifact detection was performed as described 
in( Lustenberger et al., 2015 ). Channels containing artifacts in more than 
5% of all 20 ‑sec epochs were excluded from further analysis. The record- 
ings were then re-referenced to the average of O1 and O2, as these 
4 
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Fig. 3. Slow wave slope during the first hour of Non-Rapid Eye Move- 
ment (NREM) sleep and the slow wave slope change across the night. 
Values are provided for patients (black diamonds) and control partic- 
ipants (grey circles). 
electrodes were available for all EEG recordings and slow wave activity 
(SWA) is typically most prominent in anterior regions in the age range 
of the investigated participants ( Werth et al., 1997 ; Finelli et al., 2001 ; 
Kurth et al., 2010b , 2012 ). 
A slow wave detection algorithm based on the method first described 
by ( Riedner et al., 2007 ) was used for the detection of slow waves. EEG 
signals from all derivations were band-pass filtered (0.5–4.0 Hz, stop- 
band 0.1 and 10 Hz) using a Chebyshev Type II filter (MATLAB, The 
MathWorks Inc, Natick, MA). Maximal attenuation in the passband was 
3 dB and minimal attenuation in the stopband was 10 dB. Negative 
deflections of the EEG signal were depicted as ‘negative half-waves’. 
Negative half-waves with an interval of 0.25 to 1.0 s between the zero- 
crossings, i.e. wave frequency 0.5–2 Hz, were considered slow waves. 
These were detected in all artifact-free epochs of NREM sleep. Then, 
slow waves occurring in the first and last hour of NREM sleep were se- 
lected for slope analyzes, as has been performed in previous pathological 
and physiological pediatric data ( Bölsterli et al., 2011 ; Fattinger et al., 
2015 ; Kurth et al., 2016 ). Slopes of slow waves were calculated by divid- 
ing the amplitude of the most negative deflection by the interval until 
the next zero-crossing ( Kurth et al., 2010a ) ( Fig. 1 ). Subsequently, they 
were corrected for amplitude as described in earlier work by calculating 
their value at the amplitude of 75 𝜇V (further termed ‘slope’), because 
amplitude and slope are inherently correlated ( Bölsterli et al., 2017 , 
2011 ; Bölsterli Heinzle et al., 2014 ). Furthermore, numbers of detected 
slow waves were determined for the FH of NREM sleep, LH of NREM 
sleep, and for the total time spent in NREM sleep, i.e. from the first to 
the last EEG epoch scored as NREM sleep. Mean slopes and numbers 
of detected slow waves were calculated for electrodes Fp1, Fp2, T3 or 
T5, and T4 or T6 (dependent on availability). In a second step, these 
values were averaged across these electrodes. The absolute and relative 
(i.e. with respect to the total sleep time) durations of sleep stages were 
calculated based on sleep stage-scored EEG epochs. 
2.4. Statistical analysis 
Statistics were conducted with IBM SPSS Statistics (IBM Corp. Re- 
leased 2017. IBM SPSS Statistics for Windows, Version 25.0. Armonk, 
NY: IBM Corp.). The one patient (#5) in whom the EEG was recorded 
clearly after clinical recovery, i.e. 4 years after the last manifestation of 
active disease, was excluded from quantitative statistical analysis. The 
corresponding slow wave analysis results were merely described quali- 
tatively. In the statistical analysis, we included only those patient EEG 
recordings for which clinicians evaluated the hypnograms as normal, 
to eliminate influences of pathological sleep architecture on potential 
group differences in slow wave characteristics. This left 6 patients with 
8 EEGs for statistical comparison to 30 controls. For each patient with 
two consecutive EEGs (designated EEG A and B, respectively), ages at 
time of recording (2 to 10 weeks apart) and EEG analysis outcomes were 
averaged before any further analysis. Subsequently, statistical analysis 
was repeated, including also the patients and EEGs that showed patho- 
logically fragmented sleep as described above. The results thereof are 
only reported in detail if they deviated from those previously reported. 
For the analysis of slow wave slope variables between the two groups 
of participants, a 2 × 2 mixed ANOVA was performed with the within- 
subject factor ‘hour’ (FH vs. LH) and the between-subject factor ‘group’ 
(patients vs. controls). Standardized residuals were checked for the as- 
sumption of normal distribution (Shapiro-Wilk test). Following a sig- 
nificant interaction, we performed a priori defined post hoc tests, i.e. 
two-tailed independent samples t -tests, comparing slopes during the FH 
and the LH between patients and controls, with Bonferroni correction for 
multiple comparisons (realized by multiplying p -values by the number 
of post hoc comparisons). In case residuals of the mixed ANOVA were 
deviating from a normal distribution, pairwise non-parametric proce- 
dures (two-tailed Mann-Whitney U -tests) with Bonferroni correction for 
multiple comparisons were directly performed instead, comparing the 
slope changes between the FH and the LH, slopes during the FH, and 
slopes during the LH between patients and controls. 
We compared further sleep EEG characteristics, i.e. numbers of de- 
tected slow waves and distribution of sleep stage distribution, directly 
between the groups. As some of the variables were not normally dis- 
tributed, we applied non-parametric testing (two-tailed Mann-Whitney 
U -test) to all these variables. 
Pearson correlation coefficients were calculated to assess the signif- 
icance of associations between variables if residuals were normally dis- 
tributed. Spearman correlation coefficients are reported otherwise. The 
threshold for significance for statistical analyzes was set at p < 0.05. 
2.5. Data and code availability 
MATLAB scripts used for the analyses in this study are provided by 
the corresponding author upon reasonable request. 
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Fig. 4. Slow wave slope variables for patients (colored diamonds) and for con- 
trols in the corresponding age of a particular patient (circles of the same color 
as the corresponding diamond). Participants are ordered according to their ages 
(increasing from left to right). Values are shown for the change of the slow wave 
slope across the night (panel A), the slow wave slope during the first hour of 
Non-Rapid Eye Movement (NREM) sleep (panel B), and the slow wave slope 
during the last hour of NREM sleep (panel C). Diamonds without black borders 
represent patients who had only EEGs with abnormal sleep architecture (see also 
2. Materials and Methods) and accordingly, the healthy controls of correspond- 
ing age are indicated by circles without black lines. Patient #5, indicated with 
an asterisk ( ∗ ), was measured in remission and was therefore not included in 
the analysis of patients during active anti-NMDAR encephalitis (see 2. Materials 
and Methods for details). 
3. Results 
3.1. Changes of slow wave slopes across the night 
In the analysis of slopes of slow waves during the FH and LH of 
NREM sleep in patients (#1 (B), #2, #4, #6, #7, and #9) and con- 
trols, we found a significant main effect for both hour ( F (1, 34) = 33.31, 
p < 0.001, ANOVA) and group ( F (1, 34) = 4.65, p = 0.038, ANOVA). This 
signifies that slopes were, in general, higher during the FH than during 
the LH ( + 54.02 ± 9.36 𝜇V/s, difference of means ± standard error of dif- 
ference, based on estimated marginal means) and overall higher in con- 
trols compared to patients ( + 43.02 ± 19.95 𝜇V/s). Importantly, there 
was a significant interaction between hour and group ( F (1, 34) = 6.91, 
p = 0.013, ANOVA). Namely, the decrease of the slope from the FH 
to the LH was significantly more pronounced in controls compared to 
patients ( − 49.21 ± 16.15 𝜇V/s, Fig. 2 ). Post hoc tests revealed that con- 
trols showed significantly steeper slopes than patients during the FH 
( + 67.62 ± 21.38 𝜇V/s, t (34) = 2.598, p = 0.022, independent samples t - 
test), whereas there was no significant difference between the groups for 
slopes during the LH (18.41 ± 25.24 𝜇V/s, t (34) = 1.074, p = 0.980, in- 
dependent samples t -test, Fig. 2 ). Besides, while controls demonstrated 
a strong correlation between the slope during the FH of NREM sleep 
and the change of the slope across the night ( r (28) = − 0.845, p < 0.001, 
Pearson correlation coefficient, Fig. 3 ), there was no equivalent find- 
ing for patients with anti-NMDAR encephalitis ( r (4) = 0.125, p = 0.814, 
Pearson correlation coefficient, Fig. 3 ). This means for control partici- 
pants that, the steeper the slope was in the FH, the more it decreased 
towards the LH. In contrast, this relationship could not be confirmed in 
patients. 
Results were comparable when we included the three patient EEGs 
with abnormal sleep architecture (#1 (A), #3, and #8) in the analysis 
(data not shown). 
3.2. Changes in individual participants 
All controls consistently showed a decrease in the slope from the FH 
to the LH of NREM sleep (range − 198.94 to − 0.79 𝜇V/s), whereas this 
was less consistent in patients (range − 64.39 to 33.97 𝜇V/s). Most of 
the latter showed a decrease (#1, #2, #3, #5, #6, and #9), but sev- 
eral also showed an increase (#4, #7, and #8), see Table 2 and Fig. 4 . 
The overnight change of the slope in patient #5 ( − 31.57 𝜇V/s), whose 
EEG was recorded 4 years after a relapse of anti-NMDAR encephalitis, 
was within the relatively small range of the values of controls in the 
corresponding age of a given patient ( − 25.43 to − 55.96 𝜇V/s) ( Table 2 , 
Fig. 4 ). Similarly, this patient’s slope values during the FH and LH of 
NREM sleep (363.63 𝜇V/s and 332.05 𝜇V/s, respectively) were either 
within or close to the values from the controls in the corresponding age 
(361.78 to 401.19 𝜇V/s and 333.15 to 347.60 𝜇V/s, respectively). 
3.3. Further sleep EEG characteristics 
Numbers of detected slow waves during the FH of NREM, the LH of 
NREM, and all NREM of the sleep period were not different between 
the groups ( Table 3 ). Repeating the analysis after including the three 
patient recordings with severe sleep disturbance yielded a significantly 
lower number of slow waves in patients (median 1584.56, IQR 1074.69, 
U = 78.00, p = 0.022, Mann-Whitney U test) than in controls (median 
2261.25, IQR 809.19) during the FH of NREM sleep. Yet, counts of slow 
waves were not different during the LH or all NREM sleep in the sleep 
period (data not shown). 
In addition, patients did not significantly differ from controls in the 
length of any of the sleep-wake stages, apart from a longer sleep dura- 
tion (time from falling asleep to waking up) during the EEG recording 
(difference of medians + 1.73 h, U = 15.00, p = 0.001, Mann-Whitney 
U test ) ( Table 3 ). Comparable statistical outcomes were found when the 
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Table 2 
Slow wave slope values from (individual) patients with anti-NMDAR encephalitis and controls. 
Slow wave slope ( 𝜇V/s) 
Overnight difference (LH - FH) FH of NREM sleep LH of NREM sleep 
Patient group ( n = 6, mean) − 29.41(SEM 14.12) ∗ 376.67(SEM 18.34) ∗∗ 347.26(SEM 24.50) 
Control group ( n = = 30, mean) − 78.62(SEM 7.85) ∗ 444.29(SEM 10.98) ∗∗ 365.66(SEM 6.06) 
Patient #1 − 10.10 417.44 407.34 
Patient #2 − 41.74 426.72 385.98 
Patient #3 − 17.61 297.38 279.78 
Patient #4 5.91 418.20 424.11 
Patient #5ˆ − 31.57 363.63 332.05 
Patient #6 − 62.38 361.82 299.44 
Patient #7 18.18 330.36 348.54 
Patient #8 34.00 307.11 341.09 
Patient #9 − 64.39 322.50 258.11 
∗ Significant interaction (2 × 2 mixed ANOVA with a within-subject factor (FH vs. LH) and a between-subject 
factor (patients vs. controls), p < 0.05). 
∗∗ Significant difference (two-tailed independent samples t -test, p < 0.05, Bonferroni corrected for multiple 
comparisons by multiplying the p -value by the number of tests) between patients and controls. ̂ Not included 
in statistical analysis, but slow wave analysis results assessed individually (see 2. Materials and Methods for 
details)FH = first hour (of NREM sleep); LH = last hour (of NREM sleep); NREM = Non-Rapid Eye Movement. 
Table 3 
Further sleep EEG characteristics from patients with anti-NMDAR encephali- 
tis and controls. 
Patients ( n = 6) Controls ( n = 30) P - 
value Slow wave count (#) Slow wave count (#) 
FH of NREM sleep 1976 (1071) 2425 (757) 0.146 
LH of NREM sleep 2099 (513) 2189 (842) 0.770 
Total NREM sleep 10,901 (4975) 10,153 (4894) 0.544 
Absolute (hrs) Relative (%) Absolute (hrs) Relative (%) Absolute (hrs) Relative (%) 
Sleep period 10.07 (1.54) N.A. 8.37 (1.48) N.A. < 0.001 ∗ N.A. 
Wake (cont.) 0.21 (0.58) 2.26 (1.83) 0.09 (0.31) 1.11 (4.15) 0.924 0.855 
Wake (cum.) 0.64 (1.07) 7.14 (8.81) 0.43 (0.78) 5.49 (7.66) 0.733 0.823 
NREM 1 0.43 (1.62) 4.46 (9.14) 0.48 (0.38) 5.57 (4.00) 0.412 0.513 
NREM 2/3 5.74 (1.42) 63.62 (27.26) 5.49 (1.37) 69.21 (13.31) 0.667 0.564 
REM 2.06 (1.32) 21.39 (8.98) 1.46 (0.84) 18.27 (7.24) 0.627 0.749 
Variables are described by median and interquartile range (between paren- 
theses). Two-tailed Mann-Whitney U -tests were used in statistical compar- 
isons between patients and controls. 
∗ Variables significantly different ( p < 0.05) between patients and con- 
trols.cont. = continuous (longest period); cum. = cumulative; hrs = hours; 
N.A. = not applicable; NREM = Non-Rapid Eye Movement (sleep); REM = 
Rapid Eye Movement (sleep); Sleep period = time from the beginning to the 
end of sleep (including periods of wakefulness). 
three patient EEGs with disturbance of sleep architecture were included 
for analysis (data not shown). 
3.4. Participants’ ages and changes of slopes across the night 
Healthy individuals showed smaller overnight decreases of slow 
wave slopes with increasing age (Spearman’s rho(28) = 0.724, p < 0.001, 
Fig. 5 ). Contrastingly, such an age-related effect was not evident in pa- 
tients (Spearman’s rho(4) = 0.086, p = 0.872). Results were comparable 
when the three initially excluded patient EEGs were added to the anal- 
ysis ( Fig. 5 ). 
4. Discussion 
In this study, we hypothesized that changes of slow wave slopes from 
the FH to the LH of NREM sleep, an indirect measure of synaptic plas- 
ticity ( Riedner et al., 2007 ; Vyazovskiy et al., 2009 ), are altered in a 
human model of NMDAR deficiency caused by anti-NMDAR antibodies, 
i.e. patients with anti-NMDAR encephalitis. Results confirmed that the 
overnight decrease of the slope is significantly smaller for patients than 
for healthy controls, accompanied by significantly smaller slopes dur- 
ing the FH of NREM sleep. Contrastingly, the slope during the LH of 
NREM sleep does not significantly differ between patients and controls. 
These results are in support of our hypothesis and, therefore, suggest 
that the analyzed sleep EEG markers for synaptic plasticity are sensi- 
tive to a NMDAR deficiency as evident in anti-NMDAR encephalitis. We 
conclude that synaptic plasticity seems altered in this human model of 
NMDAR deficiency. 
Various studies have proposed the functional involvement of corti- 
cal NMDAR in slow wave sleep (NREM stage 3) ( Armstrong-James and 
Fox, 1988 ; Bazhenov et al., 2002 ; Duncan et al., 2013 ). Yet, disruption 
of NMDAR function in animals revealed that these receptors are addi- 
tionally engaged in changes of EEG slow waves following synaptic po- 
tentiation during wakefulness ( Campbell and Feinberg, 1996 ; Miyamoto 
et al., 2003 ). Electro-encephalographic abnormalities have also been in- 
vestigated in anti-NMDAR encephalitis patients, i.e. human models of 
NMDAR deficiency ( Benjumea-Cuartas et al., 2017 ; Gitiaux et al., 2013 ; 
Nosadini et al., 2015 ). However, to the best of our knowledge, this is 
the first study comparing slow wave characteristics during NREM sleep 
between patients with anti-NMDAR encephalitis and healthy individu- 
als. 
The synaptic homeostasis hypothesis may contribute to the under- 
standing of the observations in patients with functional NMDAR de- 
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Fig. 5. Participants’ age at the time of the EEG recording and change 
of the slope across the night. Patient values are shown by uniquely 
colored diamonds, whereas values from control participants in the 
corresponding age of a particular patient are represented by circles 
of the same color as the corresponding diamond. Diamonds without 
a black line denote EEGs of which hypnograms were determined by 
a clinician to demonstrate abnormal sleep architecture (see 2. Ma- 
terials and Methods for a specification), with corresponding circles 
lacking a black border. Note that patient #1 had one EEG with abnor- 
mal sleep architecture (indicated by a diamond without black border) 
and one EEG with normal sleep architecture (indicated by a diamond 
with black border). Accordingly, the circles representing control EEGs 
have black borders in this case. As the residuals of the variables plot- 
ted were not normally distributed, Spearman correlation coefficients 
were calculated. In the figure, the linear regression line for patients 
(black, dashed) is for illustrative purposes only. 
ficiency. It states that the degree of net synaptic downscaling during 
sleep is closely tied to the net increase in synaptic strength during prior 
wakefulness ( Tononi and Cirelli, 2014 ). Synaptic strengthening dur- 
ing wakefulness is the result of long-term potentiation (LTP) of corti- 
cal circuits, which is assumed to be the primary mechanism of learn- 
ing ( Dupuis et al., 2014 ). Numerous studies suggested that the synaptic 
strength of cortical connections is reflected by the slope of slow waves 
( Esser et al., 2007 ; Riedner et al., 2007 ; Vyazovskiy et al., 2009 ). As NM- 
DAR are crucial for the induction of LTP ( Collingridge and Bliss, 1987 ), 
the smaller slopes during the FH of NREM sleep in patients could indi- 
cate less LTP during wakefulness because of NMDAR deficiency. 
However, NMDAR also play a role in promoting long-term de- 
pression (LTD) of synaptic networks ( González-Rueda et al., 2018 ; 
Nabavi et al., 2013 ). LTD is predominant during sleep, causing a net 
decrease of synaptic strength ( Tononi and Cirelli, 2014 ). The smaller 
slope decrease in patients with NMDAR deficiency may, therefore, in- 
dicate that also LTD is impaired. As patients were at different stages 
of their disease, different degrees of NMDAR deficiency and thus al- 
terations in synaptic plasticity were expected, which is supported by 
the high variability of overnight changes of slopes in patients ( Table 2 , 
Fig. 4 ). Moreover, to achieve homeostasis of synaptic strength, we would 
expect these overnight changes of slopes to relate to the level at the be- 
ginning of sleep resulting from previous wakefulness. The lack of a cor- 
relation between slopes during the FH of NREM sleep and their change 
during sleep in patients ( Fig. 3 ) implies that the homeostatic regula- 
tion of slow waves is disrupted. This indicates a dysfunction of synaptic 
homeostasis independent of smaller slopes at the beginning of sleep. 
Functional NMDAR are considered crucial in the maintenance of 
normal sleep patterns ( Tomita et al., 2015 ; Vataev et al., 2014 ). Aber- 
rant sleep patterns, observed in patients with anti-NMDAR encephali- 
tis ( Florance et al., 2009 ; Gitiaux et al., 2013 ; Irani et al., 2010 ), may 
theoretically influence the overnight changes of slow waves. To mini- 
mize such a confounding effect, only patient EEGs with visually normal 
appearing hypnograms were included in the main statistical analysis. 
Besides longer total sleep periods in patients, neither durations and pro- 
portions of sleep stages, nor the numbers of detected slow waves dif- 
fered between patients and controls ( Table 3 ). Additionally, by includ- 
ing controls with similar age as patients, we prevented that age-related 
differences in overnight slope decrease – as confirmed to exist in healthy 
subjects ( Fig. 5 ) – would have driven the outcomes. Therefore, the al- 
tered slow wave slope values in our patients are likely to be the result 
of factors beyond altered sleep architecture and age. 
The majority of patients in this study were female (7/9), correspond- 
ing with the fact that females are predisposed for the development of 
anti-NMDAR encephalitis ( Suh-Lailam et al., 2013 ). One of them, pa- 
tient #5, was measured more than 5 years after diagnosis and about 4 
years after a relapse of the disease. She had no clinical sequelae. Clini- 
cal recovery from anti-NMDAR encephalitis occurs due to a decrease of 
anti-NMDAR antibodies, leading to the recuperation of NMDAR function 
( Hughes et al., 2010 ). Recuperated NMDAR function could be explana- 
tory for results from patient #5, being within or close to the narrow 
range of values of controls in the corresponding age of a given patient 
( Fig. 4 ). However, since we do not have an EEG during active disease, 
it remains unknown whether slow wave slope variables were altered at 
that time. Reversibility of pathologically altered overnight changes of 
slow wave slopes has been shown in ESES ( Bölsterli et al., 2017 ), a dis- 
ease that has been linked to a genetically determined gain of NMDAR 
function ( Carvill et al., 2013 ; Lemke et al., 2013 ; Lesca et al., 2013 ). 
This study also has limitations. One of them is certainly the small 
number of patients included ( n = 9). However, given the rarity of pedi- 
atric anti-NMDAR encephalitis ( Leypoldt et al., 2013 ) and the scarcity 
of whole-night EEGs in its patients, we believe the size of our dataset 
is reasonably large. In particular, the large control group with the same 
age distribution rendered it unlikely that differences arose from the se- 
lected controls since it accounted for the variance that exists between 
individuals in a specific age range. Additionally, 9/21 EEGs were not 
analyzable due to artifacts and severely altered background activity pre- 
venting sleep stage scoring. Patients in the acute phase of the disease are 
frequently agitated and suffer hyper-motor movement disorders; both 
reasons for EEG artifacts. These issues may have introduced a selection 
bias towards patients less affected at the time of the EEG. This possi- 
ble bias would reduce differences compared to healthy controls. Impor- 
tantly, despite the small sample size and EEGs of rather less affected 
individuals, we nonetheless demonstrate significant group effects. 
Another limitation of this retrospective study is that it is unknown 
whether participants slept during the day before the night of the EEG 
recording. For those who did, slopes in the FH of NREM sleep during the 
EEG recording may have been lowered by both a reduced time of synap- 
tic potentiation during wakefulness and a decrease of synaptic strength 
during this daytime sleep. Moreover, lacking information on the occur- 
rence of seizures in patients the day preceding their whole-night EEGs 
could have additionally systematically impacted the results. However, 
since seizures have been shown to be related to increased SWA and slope 
of slow waves in the sleep EEG ( Boly et al., 2017 ), one would expect 
an increase of slope of slow waves in the sleep period after wake-time 
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seizures. As this would have weakened our results, the differences be- 
tween patients and controls would be even stronger when accounting 
for this. 
A possible confounder could have been that most of the patients with 
active disease underwent drug treatment at the time of the EEG registra- 
tion. This included corticosteroids and a variety of anti-seizure agents 
(Supplementary Table 1). Various substances have been suggested to 
alter slow wave sleep in different directions ( Holsboer et al., 1988 ; 
Legros and Bazil, 2003 ). In earlier studies of our group, we showed that 
corticosteroids reduce the slope of slow waves in infants with infantile 
spasms. However, the overnight change of slope was not investigated 
( Fattinger et al., 2015 ). Due to the small sample size in this study, the 
effect of corticosteroids could only be analyzed qualitatively. Slope val- 
ues during the FH and LH, as well as overnight changes of the slope 
in patients on corticosteroids, were below, within, and above the lev- 
els of controls ( Fig. 4 ). Hence, a systematic influence of corticosteroid 
treatment on how slope values differed from the controls in the corre- 
sponding age of a given patient is highly unlikely. Additionally, the wide 
variety of anti-seizure drugs hindered grouping of patients to accurately 
estimate their effects. Consequently, we cannot exclude an influence of 
anti-seizure drug treatments on our results, even though a systematic 
effect is improbable because of the large variability in treatments. De- 
spite these limitations, we believe that our study is unique as it contains 
a group of young patients with a very rare, yet well-defined disease 
(by the occurrence of clinical symptoms and anti-NMDAR antibodies), 
which we compared to a large healthy control group of the same age 
and (nearly) same sex distribution. 
Future perspectives related to this first study on overnight changes of 
slow wave slopes in a human model of NMDAR deficiency would be to 
conduct prospective and ideally longitudinal multicenter studies with 
standardized data acquisition (clinical, laboratory, imaging and EEG 
data) in larger samples of patients with anti-NMDAR encephalitis. Such 
studies could clarify whether dysregulated changes of slow wave slopes 
across the night can account for clinical symptoms and if recovery of 
overnight changes of the slopes is accompanied by a clinical recovery in 
patients. Alternatively, NMDAR-related parameters could be estimated 
by the use of generative models such as dynamic causal models (DCM), 
an approach that has been applied in previous studies in anti-NMDAR 
encephalitis ( Cooray et al., 2015 ; Rosch et al., 2018 ; Symmonds et al., 
2018 ), but not with regard to sleep EEG characteristics. Besides, more di- 
rect markers of functional NMDAR, for example levels of autoantibodies 
against NMDAR, could be related to the EEG markers of synaptic plas- 
ticity. This would be a next step towards a novel, clinically applicable, 
electrophysiological biomarker for pathologies of synaptic plasticity. 
In conclusion, patients with anti-NMDAR encephalitis compared to 
controls show a smaller decrease of slow wave slopes over the course of 
the night and smaller slopes at the beginning of the night. As these pa- 
tients are known to have reduced functional NMDAR and as changes in 
slow wave slopes have been suggested to reflect synaptic plasticity, our 
results support the presumption that synaptic plasticity during sleep and 
wakefulness, including synaptic homeostasis, is hampered due to func- 
tional NMDAR deficiency. In the future, the slope of slow waves might 
be used as an instrument for recognition of altered neuronal plasticity, 
for example due to altered NMDAR function in diseases and physiolog- 
ical situations such as learning or normal development. 
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